These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2778018)

  • 21. Atrial natriuretic peptide and patent ductus arteriosus in preterm infants.
    Rascher W; Seyberth HW
    Arch Dis Child; 1987 Nov; 62(11):1165-7. PubMed ID: 2961310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin levels: predictors of indomethacin responsiveness.
    Hammerman C; Zaia W; Berger S; Strates E; Aldousany A
    Pediatr Cardiol; 1986; 7(2):61-5. PubMed ID: 3467304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simple, rapid technique for operative closure of patent ductus arteriosus in the premature infant.
    Kron IL; Mentzer RM; Rheuban KS; Nolan SP
    Ann Thorac Surg; 1984 May; 37(5):422. PubMed ID: 6712346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants.
    Amitai Y; Hammerman C
    Arch Dis Child Fetal Neonatal Ed; 2012 Jan; 97(1):F76. PubMed ID: 22090351
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.
    Harris SL; More K; Dixon B; Troughton R; Pemberton C; Horwood J; Ellis N; Austin N
    Eur J Pediatr; 2018 Apr; 177(4):521-532. PubMed ID: 29352349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation, High-sensitivity C-reactive Protein, and Persistent Patent Ductus Arteriosus in Preterm Infants.
    Hillman M; Meinarde L; Rizzotti A; Cuestas E
    Rev Esp Cardiol (Engl Ed); 2016 Jan; 69(1):84-5. PubMed ID: 26671826
    [No Abstract]   [Full Text] [Related]  

  • 27. Prostaglandins in patients ductus arteriosus.
    Lucas A; Mitchell MD
    Lancet; 1978 Oct; 2(8096):937-8. PubMed ID: 81944
    [No Abstract]   [Full Text] [Related]  

  • 28. Application of photodiode array UV detection in the development of stability-indicating LC methods: determination of mefenamic acid.
    Maron N; Wright G
    J Pharm Biomed Anal; 1990; 8(1):101-5. PubMed ID: 2102261
    [No Abstract]   [Full Text] [Related]  

  • 29. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants.
    Choi BM; Lee KH; Eun BL; Yoo KH; Hong YS; Son CS; Lee JW
    Pediatrics; 2005 Mar; 115(3):e255-61. PubMed ID: 15687418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular biomarkers pro-atrial natriuretic peptide and pro-endothelin-1 to monitor ductus arteriosus evolution in very preterm infants.
    Grass B; Baumann P; Arlettaz R; Fouzas S; Meyer P; Spanaus K; Wellmann S
    Early Hum Dev; 2014 Jun; 90(6):293-8. PubMed ID: 24661445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum brain natriuretic peptide for prediction of successful medical treatment of patent ductus arteriosus in premature infants.
    Ohashi A; Kaneko K
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):261-2. PubMed ID: 19577111
    [No Abstract]   [Full Text] [Related]  

  • 32. "Shunt index" can be used to predict clinically significant patent ductus arteriosus in premature neonates in early post-natal life.
    Yapakçı E; Ecevit A; Törer B; Ince DA; Gökdemir M; Gülcan H; Tarcan A
    Cardiol Young; 2014 Aug; 24(4):605-9. PubMed ID: 23816200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does ibuprofen treatment in patent ductus arteriosus alter oxygen free radicals in premature infants?
    Akar M; Yildirim TG; Sandal G; Bozdag S; Erdeve O; Altug N; Uras N; Oguz SS; Dilmen U
    Cardiol Young; 2017 Apr; 27(3):507-511. PubMed ID: 27319277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement by HPLC of midazolam and its major metabolite, 1-hydroxymidazolam in plasma of very premature neonates.
    Lee TC; Charles B
    Biomed Chromatogr; 1996; 10(2):65-8. PubMed ID: 8924728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating prostaglandin E2 concentrations and incidence of patent ductus arteriosus in preterm infants with respiratory distress syndrome.
    Clyman RI; Brett C; Mauray F
    Pediatrics; 1980 Nov; 66(5):725-9. PubMed ID: 7432878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic solid phase extraction of mefenamic acid from biological samples based on the formation of mixed hemimicelle aggregates on Fe(3)O(4) nanoparticles prior to its HPLC-UV detection.
    Beiraghi A; Pourghazi K; Amoli-Diva M; Razmara A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():46-52. PubMed ID: 24321760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and echocardiographic diagnosis of patent ductus arteriosus in premature neonates.
    Chiruvolu A; Punjwani P; Ramaciotti C
    Early Hum Dev; 2009 Mar; 85(3):147-9. PubMed ID: 19217224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patent ductus arteriosus in premature infants.
    POWELL ML
    Med J Aust; 1963 Jul; 2():58-60. PubMed ID: 13985828
    [No Abstract]   [Full Text] [Related]  

  • 39. Microanalysis of amoxicillin, flucloxacillin, and rifampicin in neonatal plasma.
    Pullen J; Stolk LM; Neef C; Zimmermann LJ
    Biomed Chromatogr; 2007 Dec; 21(12):1259-65. PubMed ID: 17604357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodialysis of mefenamic acid in uremic patients.
    Wang LH; Lee CS; Marbury TC
    Am J Hosp Pharm; 1980 Jul; 37(7):956-8. PubMed ID: 7395889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.